Xiuchao Wang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma (NCT07475234) | Xiuchao Wang | 2026-03-01 |
Track Xiuchao Wang automatically
Every clearance here is in the API, with alerts when new ones post.